Theravance Biopharma TBPH Business Segments — Operating Expenses

Similar metrics at other companies

MCRISingle Reportable — Operating Expenses

$108.96M+3.2%

IOVASingle Reportable — Operating Expenses

$107.98M-12.1%

MCRISingle Reportable — Operating Costs And Expenses

$17.73M+4.7%

IMNMSingle Reportable — Operating Expenses

-$59.33M-24.7%

ALMSSingle Reportable — Operating Expenses

$100.15M-15.8%

MCRISingle Reportable — Other Cost And Expense Operating

$1.59M+237%

Questions, answered.

What is Theravance Biopharma's business segments — operating expenses?

Theravance Biopharma (TBPH) reported business segments — operating expenses of $27.18M in Q1 2026.

How has Theravance Biopharma's business segments — operating expenses changed year-over-year?

Theravance Biopharma's business segments — operating expenses decreased by 8.9% year-over-year, from $29.82M to $27.18M.

What is the long-term trend for Theravance Biopharma's business segments — operating expenses?

Over 2 years (2023 to 2025), Theravance Biopharma's business segments — operating expenses has grown at a -1.1% compound annual growth rate (CAGR), from $113.46M to $111.07M.

What does business segments — operating expenses mean?

This represents the total aggregate costs incurred to operate the business, including research, marketing, and administrative functions. It is the primary metric for assessing the overall cost structure and operational efficiency of the organization.